Literature DB >> 7737980

Molecular cloning and characterization of mouse estradiol 17 beta-dehydrogenase (A-specific), a member of the aldoketoreductase family.

Y Deyashiki1, K Ohshima, M Nakanishi, K Sato, K Matsuura, A Hara.   

Abstract

Several mammalian livers contain monomeric 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) with A-stereospecificity in hydrogen transfer, which differs from the B-specific dimeric enzyme of human placenta in its ability to catalyze the oxidoreduction of xenobiotic trans-dihydrodiols of aromatic hydrocarbons and carbonyl compounds. Here, we report the isolation and characterization of a mouse cDNA clone encoding monomeric 17 beta-HSD of the liver. This clone had an entire coding region for a protein of 323 amino acid residues with a molecular weight of 37,055. The deduced sequence of the protein aligned with a high degree of identity with rat and rabbit 20 alpha-HSDs, rat and human 3 alpha-HSD/dihydrodiol dehydrogenases, and bovine prostaglandin F synthase, which are members of the aldoketoreductase family, but was distinct from human 17 beta-HSD and carbonyl reductase, members of the short chain dehydrogenases. The expression of the cDNA in Escherichia coli resulted in synthesis of a protein that was active toward androgens, estrogens, and xenobiotic substrates. The recombinant and mouse liver 17 beta-HSDs also exhibited low 20 alpha-HSD activity toward progestins, which is similar to bifunctional activity of human placental 17 beta-HSD. Therefore, the mouse enzyme was given the designation of estradiol 17 beta-dehydrogenase (A-specific). Northern analysis of mouse tissues revealed the existence of a single 1.7-kilobase 17 beta-HSD mRNA species in the liver, kidney, testis, and stomach. The liver mRNA content was considerably more abundant than those found in the other tissues, as 17 beta-HSD protein was mainly detected in the liver by Western analysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7737980     DOI: 10.1074/jbc.270.18.10461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Estrogen metabolism as a regulator of estrogen action in the mammary gland.

Authors:  M Miettinen; V Isomaa; H Peltoketo; D Ghosh; P Vihko
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-07       Impact factor: 2.673

2.  Crystallization and preliminary X-ray diffraction analysis of mouse 3(17)alpha-hydroxysteroid dehydrogenase.

Authors:  Ossama El-Kabbani; Syuhei Ishikura; Armin Wagner; Clemens Schulze-Briese; Akira Hara
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-06-23

Review 3.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

4.  Cloning of mouse 17beta-hydroxysteroid dehydrogenase type 2, and analysing expression of the mRNAs for types 1, 2, 3, 4 and 5 in mouse embryos and adult tissues.

Authors:  M V Mustonen; M H Poutanen; V V Isomaa; P T Vihko; R K Vihko
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

Review 5.  Comparative anatomy of the aldo-keto reductase superfamily.

Authors:  J M Jez; M J Bennett; B P Schlegel; M Lewis; T M Penning
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

6.  Activation of human liver 3 alpha-hydroxysteroid dehydrogenase by sulphobromophthalein.

Authors:  K Matsuura; Y Tamada; Y Deyashiki; Y Miyabe; M Nakanishi; I Ohya; A Hara
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

7.  Structure of the ternary complex of human 17beta-hydroxysteroid dehydrogenase type 1 with 3-hydroxyestra-1,3,5,7-tetraen-17-one (equilin) and NADP+.

Authors:  M W Sawicki; M Erman; T Puranen; P Vihko; D Ghosh
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

8.  Tissue distribution, ontogeny, and chemical induction of aldo-keto reductases in mice.

Authors:  Matthew Pratt-Hyatt; Andrew J Lickteig; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2013-05-09       Impact factor: 3.922

9.  In vivo and in vitro expression of steroid-converting enzymes in human breast tumours: associations with interleukin-6.

Authors:  V Speirs; D S Walton; M C Hall; S L Atkin
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.